Search for dissertations about: "Spondyloarthritis"
Showing result 1 - 5 of 7 swedish dissertations containing the word Spondyloarthritis.
-
1. Prevalence, physical activity and work in patients with spondyloarthritis
Abstract : Spondyloarthritis (SpA) is a group of interrelated inflammatory rheumatic diseases with the sub-diagnoses ankylosing spondylitis (AS), psoriatic arthritis (PsA), arthritis-associated inflammatory bowel disease (Aa-IBD), undifferentiated SpA (USpA), where stiffness and pain are key symptoms. Insidious onset back pain, morning stiffness, waking up at night, and improvement from exercise are common characteristics. READ MORE
-
2. Pain and physical function in patients with spondyloarthritis
Abstract : AbstractAnkylosing spondylitis (AS) and undifferentiated spondyloarthritis (USpA) are two subgroups of the rheumatic disease spondyloarthritis (SpA). The diseases typically debut in early adulthood with periods of fluctuating and persistent pain and stiffness, and can result in consequences such as impaired functioning and reduced quality of life. READ MORE
-
3. Cardiovascular outcomes and extra-articular manifestations in patients with spondyloarthritis
Abstract : Background: Spondyloarthritis (SpA) is a cluster of rheumatic diseases with similar clinical features, including association with extra-articular manifestations such as anterior uveitis (AU), inflammatory bowel disease (IBD) and psoriasis. Ankylosing spondylitis (AS), psoriatic arthritis (PsA) and undifferentiated SpA (uSpA) are the major subtypes of SpA. READ MORE
-
4. Spatial Tissue Mapping on Joint Biopsies from Arthritis Patients
Abstract : Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that mainly affects joints, causing discomfort and pain that severely reduces the life quality of affected individuals. Its etiology is largely unknown, but some pathophysiological mechanisms have been identified. READ MORE
-
5. Measure for measure. Outcome assessment of arthritis treatment in clinical practice
Abstract : Objective: To investigate (i) the performance and agreement between various activity indices and response criteria in TNF-blockade of RA; (ii) the predictive ability of different response criteria and disease activity states regarding continuation of anti-TNF treatment of RA; (iii) Euro-QoL-5-dimensions utility development during TNF blockade of RA, PsA and SpA. Also, (iv) to develop a simple, utility-based outcome measure, the number needed to treat per quality adjusted life year gained (NNQ) and apply it in RA, PsA and SpA patients on anti-TNF treatment. READ MORE